A citation-based method for searching scientific literature

P J Hunt, A M Richards, E A Espiner, M G Nicholls, T G Yandle. J Clin Endocrinol Metab 1994
Times Cited: 142







List of co-cited articles
1138 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Dwarfism and early death in mice lacking C-type natriuretic peptide.
H Chusho, N Tamura, Y Ogawa, A Yasoda, M Suda, T Miyazawa, K Nakamura, K Nakao, T Kurihara, Y Komatsu,[...]. Proc Natl Acad Sci U S A 2001
328
35


C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain.
T Sudoh, N Minamino, K Kangawa, H Matsuo. Biochem Biophys Res Commun 1990
933
31

Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide.
S Suga, K Nakao, K Hosoda, M Mukoyama, Y Ogawa, G Shirakami, H Arai, Y Saito, Y Kambayashi, K Inouye. Endocrinology 1992
655
29


Furin-mediated processing of Pro-C-type natriuretic peptide.
Chengliang Wu, Faye Wu, Junliang Pan, John Morser, Qingyu Wu. J Biol Chem 2003
142
27


Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway.
Akihiro Yasoda, Yasato Komatsu, Hideki Chusho, Takashi Miyazawa, Ami Ozasa, Masako Miura, Tatsuya Kurihara, Tomohiro Rogi, Shoji Tanaka, Michio Suda,[...]. Nat Med 2004
262
25

Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux.
Cynthia F Bartels, Hulya Bükülmez, Pius Padayatti, David K Rhee, Conny van Ravenswaaij-Arts, Richard M Pauli, Stefan Mundlos, David Chitayat, Ling-Yu Shih, Lihadh I Al-Gazali,[...]. Am J Hum Genet 2004
227
23

Action of C-type natriuretic peptide in isolated canine arteries and veins.
C M Wei, L L Aarhus, V M Miller, J C Burnett. Am J Physiol 1993
137
22



A new natriuretic peptide in porcine brain.
T Sudoh, K Kangawa, N Minamino, H Matsuo. Nature 1988
20

C-type natriuretic peptide, a novel antifibrotic and antihypertrophic agent, prevents cardiac remodeling after myocardial infarction.
Takeshi Soeki, Ichiro Kishimoto, Hiroyuki Okumura, Takeshi Tokudome, Takeshi Horio, Kenji Mori, Kenji Kangawa. J Am Coll Cardiol 2005
129
19

Design, synthesis, and actions of a novel chimeric natriuretic peptide: CD-NP.
Ondrej Lisy, Brenda K Huntley, Daniel J McCormick, Paul A Kurlansky, John C Burnett. J Am Coll Cardiol 2008
128
19

Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma.
A J Stingo, A L Clavell, D M Heublein, C M Wei, M R Pittelkow, J C Burnett. Am J Physiol 1992
236
18


Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP).
K J Koller, D G Lowe, G L Bennett, N Minamino, K Kangawa, H Matsuo, D V Goeddel. Science 1991
713
18

Natriuretic peptide regulation of endochondral ossification. Evidence for possible roles of the C-type natriuretic peptide/guanylyl cyclase-B pathway.
A Yasoda, Y Ogawa, M Suda, N Tamura, K Mori, Y Sakuma, H Chusho, K Shiota, K Tanaka, K Nakao. J Biol Chem 1998
155
18

Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications.
Lincoln R Potter, Andrea R Yoder, Darcy R Flora, Laura K Antos, Deborah M Dickey. Handb Exp Pharmacol 2009
311
18

Natriuretic peptides.
E R Levin, D G Gardner, W K Samson. N Engl J Med 1998
17

Identification of amino-terminal pro-C-type natriuretic peptide in human plasma.
T C Prickett, T G Yandle, M G Nicholls, E A Espiner, A M Richards. Biochem Biophys Res Commun 2001
92
18

Critical roles of the guanylyl cyclase B receptor in endochondral ossification and development of female reproductive organs.
Naohisa Tamura, Lynda K Doolittle, Robert E Hammer, John M Shelton, James A Richardson, David L Garbers. Proc Natl Acad Sci U S A 2004
201
17


Cardiac fibrosis in mice lacking brain natriuretic peptide.
N Tamura, Y Ogawa, H Chusho, K Nakamura, K Nakao, M Suda, M Kasahara, R Hashimoto, G Katsuura, M Mukoyama,[...]. Proc Natl Acad Sci U S A 2000
432
15

Myocardial production of C-type natriuretic peptide in chronic heart failure.
Paul R Kalra, Jonathon R Clague, Aidan P Bolger, Stefan D Anker, Phillip A Poole-Wilson, Allan D Struthers, Andrew J Coats. Circulation 2003
135
15

Regional release and clearance of C-type natriuretic peptides in the human circulation and relation to cardiac function.
Suetonia C Palmer, Timothy C R Prickett, Eric A Espiner, Timothy G Yandle, A Mark Richards. Hypertension 2009
62
24

The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system.
N Matsukawa, W J Grzesik, N Takahashi, K N Pandey, S Pang, M Yamauchi, O Smithies. Proc Natl Acad Sci U S A 1999
311
14


Natriuretic peptide system in human heart failure.
C M Wei, D M Heublein, M A Perrella, A Lerman, R J Rodeheffer, C G McGregor, W D Edwards, H V Schaff, J C Burnett. Circulation 1993
363
13

Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension.
S W John, J H Krege, P M Oliver, J R Hagaman, J B Hodgin, S C Pang, T G Flynn, O Smithies. Science 1995
492
13

Amino-terminal proCNP: a putative marker of cartilage activity in postnatal growth.
Timothy C R Prickett, Adrienne M Lynn, Graham K Barrell, Brian A Darlow, Vicky A Cameron, Eric A Espiner, A Mark Richards, Timothy G Yandle. Pediatr Res 2005
54
24

Gene expression, secretion, and autocrine action of C-type natriuretic peptide in cultured adult rat cardiac fibroblasts.
Takeshi Horio, Takeshi Tokudome, Toshiyuki Maki, Fumiki Yoshihara, Shin-Ichi Suga, Toshio Nishikimi, Masayasu Kojima, Yuhei Kawano, Kenji Kangawa. Endocrinology 2003
132
13

Systemic administration of C-type natriuretic peptide as a novel therapeutic strategy for skeletal dysplasias.
Akihiro Yasoda, Hidetomo Kitamura, Toshihito Fujii, Eri Kondo, Naoaki Murao, Masako Miura, Naotetsu Kanamoto, Yasato Komatsu, Hiroshi Arai, Kazuwa Nakao. Endocrinology 2009
79
16

Shear stress augments expression of C-type natriuretic peptide and adrenomedullin.
T H Chun, H Itoh, Y Ogawa, N Tamura, K Takaya, T Igaki, J Yamashita, K Doi, M Inoue, K Masatsugu,[...]. Hypertension 1997
160
12

Detection of C-type natriuretic peptide in human circulation and marked increase of plasma CNP level in septic shock patients.
N Hama, H Itoh, G Shirakami, S Suga, Y Komatsu, T Yoshimasa, I Tanaka, K Mori, K Nakao. Biochem Biophys Res Commun 1994
121
12

Gene and precursor structures of human C-type natriuretic peptide.
Y Tawaragi, K Fuchimura, S Tanaka, N Minamino, K Kangawa, H Matsuo. Biochem Biophys Res Commun 1991
112
12

Physiological role of silent receptors of atrial natriuretic factor.
T Maack, M Suzuki, F A Almeida, D Nussenzveig, R M Scarborough, G A McEnroe, J A Lewicki. Science 1987
12

Metabolic clearance rate and plasma half life of alpha-human atrial natriuretic peptide in man.
T G Yandle, A M Richards, M G Nicholls, R Cuneo, E A Espiner, J H Livesey. Life Sci 1986
275
12

C-type natriuretic peptide: a selective cardiovascular peptide.
A L Clavell, A J Stingo, C M Wei, D M Heublein, J C Burnett. Am J Physiol 1993
131
12

Cardiomyocyte-restricted over-expression of C-type natriuretic peptide prevents cardiac hypertrophy induced by myocardial infarction in mice.
Yong Wang, Monique C de Waard, Anja Sterner-Kock, Holger Stepan, Heinz-Peter Schultheiss, Dirk J Duncker, Thomas Walther. Eur J Heart Fail 2007
67
17

Pharmacodynamics of a novel designer natriuretic peptide, CD-NP, in a first-in-human clinical trial in healthy subjects.
Candace Y W Lee, Horng H Chen, Ondrej Lisy, Suzanne Swan, Courtney Cannon, Hsiao D Lieu, John C Burnett. J Clin Pharmacol 2009
78
15

C-type natriuretic peptide is a growth inhibitor of rat vascular smooth muscle cells.
M Furuya, M Yoshida, Y Hayashi, N Ohnuma, N Minamino, K Kangawa, H Matsuo. Biochem Biophys Res Commun 1991
183
11

Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide.
M J Lopez, S K Wong, I Kishimoto, S Dubois, V Mach, J Friesen, D L Garbers, A Beuve. Nature 1995
388
11

The pharmacokinetics of alpha-human atrial natriuretic polypeptide in healthy subjects.
K Nakao, A Sugawara, N Morii, M Sakamoto, T Yamada, H Itoh, S Shiono, Y Saito, K Nishimura, T Ban. Eur J Clin Pharmacol 1986
100
11

Heterozygous mutations in natriuretic peptide receptor-B (NPR2) are associated with short stature.
Robert C Olney, Hülya Bükülmez, Cynthia F Bartels, Timothy C R Prickett, Eric A Espiner, Lincoln R Potter, Matthew L Warman. J Clin Endocrinol Metab 2006
115
11


Cardiac hypertrophy in transgenic rats expressing a dominant-negative mutant of the natriuretic peptide receptor B.
Thomas H Langenickel, Jens Buttgereit, Ines Pagel-Langenickel, Maren Lindner, Jan Monti, Knut Beuerlein, Nidal Al-Saadi, Ralph Plehm, Elena Popova, Jens Tank,[...]. Proc Natl Acad Sci U S A 2006
99
11

Overexpression of the C-type natriuretic peptide (CNP) is associated with overgrowth and bone anomalies in an individual with balanced t(2;7) translocation.
Renata Bocciardi, Roberto Giorda, Jens Buttgereit, Stefania Gimelli, Maria Teresa Divizia, Silvana Beri, Silvio Garofalo, Sara Tavella, Margherita Lerone, Orsetta Zuffardi,[...]. Hum Mutat 2007
90
12

Chronically elevated plasma C-type natriuretic peptide level stimulates skeletal growth in transgenic mice.
Takei Kake, Hidetomo Kitamura, Yuichiro Adachi, Tetsuro Yoshioka, Tomoyuki Watanabe, Hiroaki Matsushita, Toshihito Fujii, Eri Kondo, Takanori Tachibe, Yosuke Kawase,[...]. Am J Physiol Endocrinol Metab 2009
59
18


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.